Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.10 – $3.75
12% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.67B | $15.05B | $11.94B | $9.77B | $8.97B | $10.40B | $9.22B | $7.60B |
| Cost of revenue | $15.14B | $14.05B | $11.56B | $9.13B | $8.13B | $9.79B | $8.44B | $7.20B |
| Gross profit | $1.42B | $1.08B | $378.0M | $639.0M | $682.0M | $587.0M | $776.0M | $404.0M |
| Gross margin | 8.5% | 7.2% | 3.2% | 6.5% | 7.6% | 5.6% | 8.4% | 5.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $1.14B | $275.0M | −$578.0M | $411.0M | −$176.0M | −$168.0M | −$24.0M | −$209.0M |
| EBITDA | $1.26B | $884.0M | −$378.0M | $623.0M | $87.0M | $63.0M | −$974.0M | $739.0M |
| Net income | $792.8M | $467.0M | −$310.0M | $222.0M | −$99.0M | −$232.0M | −$1.50B | $225.0M |
| Net margin | 4.8% | 3.1% | -2.6% | 2.3% | -1.1% | -2.2% | -16.3% | 3.0% |
| EPS (diluted) | 1.37 | 0.79 | -0.52 | 0.33 | -0.14 | -0.34 | -2.20 | 0.33 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $7.1B | $-0.42 | $-0.49–$-0.36 | 1 |
| 2027 | $7.8B | $0.41 | $0.35–$0.47 | 1 |
| 2028 | $7.0B | $0.44 | $0.37–$0.50 | 1 |
| 2029 | $6.1B | $0.32 | $0.27–$0.37 | 1 |
Forward consensus · source: Financial Modeling Prep
LEND LEASE CRP STPLD SECS
No one on the platform currently holds LLESF.
No tracked institution reports a position in LLESF as of their last filing.
No one on the platform has traded LLESF yet.
| +0.00% |
| $2.6B |
| — |
| HNLGYHang Lung Group Limited | $8.83 | +0.00% | $2.4B | — |
| HUFAFHufvudstaden AB (publ) | $12.78 | +0.00% | $2.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× sales vs its 0.3× historical median P/S.
Fair value ≈ $9.53 · price $2.29 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.